In severely obese patients, leptin and inflammatory cytokines inhibit kisspeptin, a GnRH release stimulator, potentially causing hypogonadism by impairing the hypothalamus–gonadotroph–gonadal axis, especially in those with leptin resistance (13). This evidence concerns the gene GNRH1 and hypogonadism.